• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MAQUET CARDIOPULMONARY AG OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MAQUET CARDIOPULMONARY AG OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Model Number BEQ-HMOD30000-USA
Device Problems Complete Blockage (1094); Device Operates Differently Than Expected (2913)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Manufacturer Narrative
(b)(4).The product is not available for return; therefore an investigation at the laboratory of the manufacturer was not possible.Trend search: a sap trend search was performed for p/n 70105.0330 failure code 0010 clotting and 2 similar complaints were found.A trackwise trend search was performed for p/n 70105.0330 d-clotting outlet side and 6 similar complaints were found.Due to this information no systemic issue could be determined.Similar complaint investigation results: the reported failure is known to mcp and was investigated within a similar complaint with the following results:sample was received by the lab.The unit was tested with bovine blood for gas exchange and pressure drop performance.The unit met all acceptance criteria.Clotting is a known phenomenon and was investigated in previous complaints.The cause of this failure was determined to not be attributed to a device related malfunction.Thus the reported failure could not be confirmed.Based on these results and the information available at this time, the oxygenator in question operated within mcp specifications.
 
Event Description
According to the customer: clots in corners on arterial side.Ecmo hour 4 arterial side of membrane clot noted at 3 o¿clock and 9 o¿clock.-heparin started at ecmo hr.-heparin off at hr 23.-heparin on at hr 27.-heparin sub therapeutic through most of the ecmo run, ptt 60-100s.-membrane changed at hour 335, electively, delta gradient was the same (per surgeon¿s request).-with new membrane no arterial side clots noted despite sub therapeutic heparin.-patient remains on ecmo.-(b)(6).-flows 400-500 l/min.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OXYGENATOR, CARDIOPULMONARY BYPASS
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
MAQUET CARDIOPULMONARY AG
rastatt
GM 
Manufacturer (Section G)
BERND RAKOW
maquet cardiopulmonary ag
kehler strasse 31
76437 rastatt
GM  
Manufacturer Contact
maquet cardiopulmonary ag
kehler strasse 31
76437 rastatt 
4972229321
MDR Report Key6348770
MDR Text Key68377341
Report Number8010762-2017-00056
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
PMA/PMN Number
K100278
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 02/22/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/22/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberBEQ-HMOD30000-USA
Device Catalogue Number701050330
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/04/2017
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
-
-